Clinical Trial Update: Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant apalutamide in men with high-risk localized or locally advanced prostate cancer after radical prostatectomy; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)

Snippet

Sponsor: Universität Münster | Conditions: Prostatic Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING